Risk for Esophageal Adenocarcinoma Not Increased With Nonerosive GERD
WEDNESDAY, Sept. 20, 2023 -- Patients with nonerosive gastroesophageal reflux disease (GERD) do not have an increased risk for esophageal adenocarcinoma compared with the general population, according to a study published online Sept. 13 in The...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Acid Reflux | Adenocarcinoma | Esophagus Cancer | Gastroenterology | Gastroesophageal Reflux Disease | GERD | Pharmaceuticals | Study